The man behind Leo Pharma's million-dollar deals takes the helm at Rhovac

After more than 10 years as CEO of Rhovac, Anders Ljungqvist steps down with immediate effect. His successor is Leo Pharma's former Head of Global Business Development.

Axel Schmidt/Reuters/Ritzau Scanpix Photo: Axel Schmidt/Reuters/Ritzau Scanpix

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles